Welcome to LookChem.com Sign In|Join Free
  • or
4-(4-Chlorophenyl)-1-(3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-1-propyl)-4-piperidinol is a complex organic compound with a molecular formula of C27H30ClN3O. It is a derivative of dibenz[b,f]azepine, a tricyclic structure that is part of the chemical structure of certain drugs, particularly those used in the treatment of mental health disorders. This specific compound features a 4-chlorophenyl group, a 3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-1-propyl side chain, and a 4-piperidinol group. The presence of the chlorine atom and the nitrogen-containing rings contribute to its potential pharmacological properties, although the exact application or activity of this particular compound would require further investigation and research.

5499-80-9

Post Buying Request

5499-80-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5499-80-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5499-80-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,9 and 9 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5499-80:
(6*5)+(5*4)+(4*9)+(3*9)+(2*8)+(1*0)=129
129 % 10 = 9
So 5499-80-9 is a valid CAS Registry Number.

5499-80-9Downstream Products

5499-80-9Relevant academic research and scientific papers

Synthesis and pharmacological characterization of novel inverse agonists acting on the viral-encoded chemokine receptor US28

Hulshof, Janneke W.,Vischer, Henry F.,Verheij, Mark H.P.,Fratantoni, Silvina A.,Smit, Martine J.,de Esch, Iwan J.P.,Leurs, Rob

, p. 7213 - 7230 (2007/10/03)

G-protein coupled receptors encoded by viruses represent an unexplored class of potential drug targets. In this study, we describe the synthesis and pharmacological characterization of the first class of inverse agonists acting on the HCMV-encoded receptor US28. It is shown that replacement of the 4-hydroxy group of lead compound 1 with a methylamine group results in a significant 6-fold increase in affinity. Interestingly, increasing the rigidity of the spacer by the introduction of a double bond also leads to a significant increase in binding affinity compared to 1. These novel inverse agonists serve as valuable tools to elucidate the role of constitutive signaling in the pathogenesis of viral infection and may have therapeutic potential as leads for new antiviral drugs.

Use of N-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis

-

, (2008/06/13)

The present invention relates to the use of N-substituted azaheterocyclic compounds or salts thereof, for the treatment of conditions related to angiogenesis.

N-substituted azaheterocyclic carboxylic acids and esters thereof

-

, (2008/06/13)

The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.

Substituted dibenz[b,f]azepines and uses thereof

-

, (2008/06/13)

The present invention relates to novel N-substituted azaheterocyclic carboxylic acids andy esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.

N-substituted azaheterocyclic carboxylic acids and esters thereof

-

, (2008/06/13)

The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5499-80-9